← FDA Drug Approvals (Drugs@FDA)

NOVOLIN N

BLA · Biologics License Application · Sponsor: NOVO NORDISK INC · Approved 1991-07-01

Drug application

FDA Application #

BLA019959

Application type

Biologics License Application

Brand name

NOVOLIN N

Generic name

HUMAN INSULIN

Active ingredients

INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Over-the-counter

Sponsor

NOVO NORDISK INC

Manufacturer

Novo Nordisk

First approval

1991-07-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown